Related Experiment Video
Updated: Sep 26, 2025
12:04
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
3.8K
Fight mutant cancer cells by … making more mutations?
1New Orleans.
Science (New York, N.Y.)
|April 21, 2022
Summary
Certain chemotherapies can introduce DNA errors, potentially activating the immune system to target and destroy cancer cells. This DNA damage response may enhance anti-tumor immunity.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- DNA damage is a known hallmark of cancer.
- Chemotherapy agents are designed to induce DNA damage in rapidly dividing cells, including cancer cells.
- The immune system plays a crucial role in recognizing and eliminating cancerous cells.
Discussion:
- This study explores the immunogenic potential of chemotherapy-induced DNA errors.
- Investigating how DNA damage can trigger an anti-tumor immune response.
- Understanding the interplay between genotoxic stress and immune surveillance in cancer.
Key Insights:
- Chemotherapies can generate neoantigens through DNA mutations, making tumors more visible to the immune system.
- DNA damage response pathways can activate immune signaling, recruiting immune cells to the tumor microenvironment.
- This mechanism offers a novel strategy for enhancing the efficacy of cancer immunotherapies.
Outlook:
- Further research into specific DNA-damaging agents and their immunomodulatory effects.
- Developing combination therapies that leverage chemotherapy-induced immunogenicity for improved cancer treatment.
- Exploring biomarkers to predict patient response to this immunogenic chemotherapy approach.
More Related Videos
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
02:21Cancers Originate from Somatic Mutations in a Single Cell
13.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:40Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
02:18Cancer
50.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
50.1K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K